Related references
Note: Only part of the references are listed.Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic Cancer
Alan R. Penheiter et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2010)
Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
H. Li et al.
CANCER GENE THERAPY (2010)
The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery
M. Hingorani et al.
CURRENT CANCER DRUG TARGETS (2010)
A probasin promoter, conditionally replicating adenovirus that expresses the sodium iodide symporter (NIS) for radiovirotherapy of prostate cancer
M. A. Trujillo et al.
GENE THERAPY (2010)
Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter
Inge Peerlinck et al.
CLINICAL CANCER RESEARCH (2009)
The potential of 211Astatine for NIS-mediated radionuclide therapy in prostate cancer
Michael J. Willhauck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Internal radiotherapy of liver cancer with rat hepatocarcinoma-intestine-pancreas gene as a liver tumor-specific promoter
Julie Herve et al.
HUMAN GENE THERAPY (2008)
α-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma
M. J. Willhauck et al.
GENE THERAPY (2008)
Application of 188Rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression
Michael J. Willhauck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Image-guided radioiodide therapy of medullary thyroid cancer after carcinoembryonic antigen promoter-targeted sodium iodide symporter gene expression
Christine Spitzweg et al.
HUMAN GENE THERAPY (2007)
Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors
Roisin M. Dwyer et al.
HUMAN GENE THERAPY (2006)
Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells
S Unterholzner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice
RM Dwyer et al.
GENE THERAPY (2006)
Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth
E Dadachova et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression
N Cengic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
In vivo radioiodide imaging and treatment of breast cancer xenografts after MUC1-driven expression of the sodium iodide symporter
RM Dwyer et al.
CLINICAL CANCER RESEARCH (2005)
Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer
IV Scholz et al.
GENE THERAPY (2005)
Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter
D Dingli et al.
BLOOD (2004)
The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid
IL Wapnir et al.
CLINICAL CANCER RESEARCH (2004)
Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in Wistar rats
J Faivre et al.
CANCER RESEARCH (2004)
In vivo imaging and tumor therapy with the sodium iodide symporter
D Dingli et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Genetically targeted radiotherapy for multiple myeloma
D Dingli et al.
BLOOD (2003)
The sodium iodide symporter: its pathophysiological and therapeutic implications
C Spitzweg et al.
CLINICAL ENDOCRINOLOGY (2002)
In vivo sodium iodide symporter gene therapy of prostate cancer
C Spitzweg et al.
GENE THERAPY (2001)
Share Paper
